Osteoporosis drugs on every 2026 Puerto Rico Part D plan
Pick a drug class, or type the drugs you want to check, and see which of the 3 stand-alone Part D plans in Puerto Rico cover each one, on what tier, and with what restrictions.
- Covered
- Covered, needs prior authorization (PA) or step therapy (ST)
- Not on the formulary
- QL 60/30d = quantity limit, 60 units per 30 days
| Drug | HealthSpring Extra Rx$50.00/moS5617-385 | HealthSpring Assurance Rx$65.70/moS5617-348 | AARP Medicare Rx Preferred from UHC$145.10/moS5820-037 |
|---|---|---|---|
| alendronategeneric Fosamax | Tier 1$0.00 | Tier 1$0.00QL 30/30d | Tier 125%QL 30/30d |
| risedronategeneric Actonel | Not covered | Not covered | Not covered |
| ibandronategeneric Boniva | Tier 317%QL 1/28d | Tier 322%QL 1/28d | Tier 325%QL 1/28d |
| Proliadenosumab | Tier 431%QL 1/180d | Tier 434%QL 1/180d | Not covered |
| denosumab biosimilarsJubbonti, Ospomyv and others | Not covered | Not covered | Tier 425%QL 1/180d |
| Evenityromosozumab | Not covered | Not covered | Not covered |
| Forteoteriparatide | Not covered | Not covered | Not covered |
| teriparatidegeneric Forteo | Tier 5PA25%QL 2.48/28d | Tier 5PA25%QL 2.48/28d | Tier 5PA25%QL 2.48/28d |
| Tymlosabaloparatide | Not covered | Not covered | Tier 5PA25%QL 1.56/30d |
Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.